Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine

Clinical trial NCT00140348 · COMPLETED

Trial details

NCT number: NCT00140348
Sponsor: Cell Genesys
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2001-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.